Molecular typing relies on molecular genetic tests and isn't however routinely offered. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferat